
RGL Pharmaceutical (OPC) Private Limited
About RGL Pharmaceutical (OPC) Private Limited
Data last updated:
RGL Pharmaceutical (OPC) Private Limited is a one person company based in Balianta, Odisha, India. It was incorporated on 21 September 2024.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U46497OD2024OPC046871.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10,000. It is led by director Pitambar Mishra.
Its latest financial statements are for the year ended 31 March 2025. The registered office is at Balianta, Odisha.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.88 Lakh. For the same year it recorded a net loss of ₹5,510 (net margin -0.9%) and EBITDA of -₹5,510 (EBITDA margin -0.9%).
Company details
Contact details
RGL Pharmaceutical (OPC) Private Limited's registered office is in Balianta, Odisha.
- Registered AddressPlot No Sg 05 Lane 3, Srikhetra Vihar, Balianta, Odisha, India – 751019
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of RGL Pharmaceutical (OPC) Private Limited
FY 2025 filings availableRGL Pharmaceutical (OPC) Private Limited reported revenue of ₹5.88 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹5,510 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹5,510 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -0.9% |
| Net Profit Margin | -0.9% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of RGL Pharmaceutical (OPC) Private Limited, buy the company report.
Board of directors of RGL Pharmaceutical (OPC) Private Limited
RGL Pharmaceutical has 1 director on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pitambar Mishra | Director | 21 Sep 2024 | 2 Years 2 Months | Current |
Peer comparison
RGL Pharmaceutical (OPC) Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals, Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bangalore Bowel Care (BBC) India Private Limited | ₹5.93 Lakh (FY 2023) | 261.0% | Bangalore, Karnataka, India | |||
| Ossflora Lifecare Private Limited | ₹5.91 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Shah Medicare Private Limited | ₹5.9 Lakh (FY 2019) | Mumbai, Maharashtra, India | ||||
| Lamfer Health Care India Private Limited | ₹5.89 Lakh (FY 2022) | Chennai, Tamil Nadu, India | ||||
| Frontsheet Pharmaceutical Private Limited | ₹5.89 Lakh (FY 2023) | 182.0% | Patna, Bihar, India | |||
| RGL Pharmaceutical (OPC) Private Limitedthis company | ₹5.88 Lakh (FY 2025) | -₹5,510 | -0.9% | Balianta, Odisha, India | ||
| Manford Pharma Private Limited | ₹5.87 Lakh (FY 2025) | Kolkata, West Bengal, India | ||||
| Gyrus Pharmaceuticals Private Limited | ₹5.85 Lakh (FY 2025) | 21.0% | Amritsar, Punjab, India | |||
| Geetanjali Pharmaceuticals (India) P. Ltd. | ₹5.85 Lakh (FY 2024) | -49.0% | Thane, Maharashtra, India | |||
| Vipik Pharma Private Limited | ₹5.84 Lakh (FY 2020) | 188.0% | Kolhapur, Maharashtra, India | |||
| Medburry Lifesciences Private Limited | ₹5.82 Lakh (FY 2025) | -16.0% | Lucnow, Uttar Pradesh, India |
To see the full peer comparison of RGL Pharmaceutical (OPC) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving RGL Pharmaceutical (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for RGL Pharmaceutical (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for RGL Pharmaceutical (OPC) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
RGL Pharmaceutical (OPC) Private Limited has 1 board change on record since 2024: 1 appointment. The latest: Pitambar Mishra was appointed as Director on 21 Sep 2024.
Frequently asked questions
RGL Pharmaceutical is an active company based in Balianta, Odisha, India. It was incorporated on 21 September 2024 (2+ years old) and is registered under CIN U46497OD2024OPC046871.
RGL Pharmaceutical has 1 current director:
- Pitambar Mishra - Director
The latest financial statements of RGL Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of RGL Pharmaceutical is U46497OD2024OPC046871. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
RGL Pharmaceutical was incorporated on 21 September 2024, making it 2+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of RGL Pharmaceutical by revenue are Bangalore Bowel Care (BBC) India Private Limited, Ossflora Lifecare Private Limited, Shah Medicare Private Limited, Lamfer Health Care India Private Limited, Frontsheet Pharmaceutical Private Limited and 5 more, all in the Healthcare industry (Multi Specialty Hospitals, Pharma Retail and Distribution).
Pitambar Mishra was appointed as Director on 21 Sep 2024.
The registered office of RGL Pharmaceutical is at Plot No Sg 05 Lane 3, Srikhetra Vihar, Balianta, Odisha, India – 751019.
RGL Pharmaceutical can be reached at its registered office: Plot No Sg 05 Lane 3, Srikhetra Vihar, Balianta, Odisha, India – 751019.
RGL Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Cuttack.

